Joseph P. Hagan
Overview
Joseph P. Hagan received an average of $2M in total compensation, including $511K in salary, at Regulus Therapeutics from 2016 to 2021. Joseph Hagan also received an average of $1M at Orexigen Therapeutics from 2009 to 2015.
- 2021
- 2020
- 2019
- 2018
- 2017
- 2016
- 2015
- 2014
- 2013
- 2012
Regulus TherapeuticsPresident & Chief Executive Officer
Regulus TherapeuticsPresident & Chief Executive Officer
Regulus TherapeuticsPresident & Chief Executive Officer
Regulus TherapeuticsPresident & Chief Executive Officer
Regulus TherapeuticsPresident & Chief Executive Officer
Regulus TherapeuticsChief Operations Officer
Orexigen TherapeuticsFormer Chief Business and Financial Officer
Orexigen TherapeuticsFormer Chief Business and Financial Officer
Orexigen TherapeuticsFormer Chief Business and Financial Officer
Orexigen TherapeuticsChief Business and Financial Officer
Source: SEC filings on April 27, 2022, April 30, 2021, April 29, 2020, July 1, 2019, April 20, 2018, April 28, 2017, May 27, 2016, April 22, 2015, April 30, 2014, April 23, 2013, and April 27, 2012.
Related executives
We found 23 more executives who work or worked at Regulus Therapeutics and Orexigen Therapeutics.
Christopher Aker
Regulus Therapeutics
General Counsel
Cris Calsada
Regulus Therapeutics
Chief Financial Officer
Daniel Chevallard
Regulus Therapeutics
Chief Financial Officer
Timothy Wright
Regulus Therapeutics
Chief Research & Development Officer
Paul Grint
Regulus Therapeutics
Chief Executive Officer
Mark Deeg
Regulus Therapeutics
Chief Medical Officer
Michael Narachi
Orexigen Therapeutics
Chief Executive Officer
Thomas Cannell
Orexigen Therapeutics
Chief Operating Officer
News
Regulus Therapeutics CEO Joseph Hagan's 2021 pay falls 22% to $1.8M
April 27, 2022
Regulus Therapeutics CEO Joseph Hagan's 2020 pay rises 16% to $2.3M
April 30, 2021
Regulus Therapeutics CEO Joseph Hagan's 2019 pay slips 14% to $2M
April 29, 2020
Regulus Therapeutics CEO Joseph Hagan's 2018 pay jumps 22% to $2.3M
July 1, 2019